Psychiatry

814 questions

Question 41Question →

A 3434-year-old man comes to the clinic requesting assistance with smoking cessation. He has smoked one and a half packs of cigarettes daily for the past 1515 years. His past medical history is significant for bipolar I disorder. His last manic episode occurred 44 years ago, and he is currently stable on valproate monotherapy without any recent depressive or manic symptoms. The patient states, 'I tried using nicotine patches and nicotine gum together last year, but the cravings were too strong and I went back to smoking within a week.' He is highly motivated to quit and asks for an oral prescription medication to help reduce his cravings. Physical examination and vital signs are within normal limits. Which of the following is the most appropriate pharmacotherapy for this patient?

Show answer & explanation

Answer: Varenicline

Answer

Varenicline is the most appropriate medication for this patient.
Varenicline is the most appropriate next step for this patient. He has severe Tobacco Use Disorder and has already failed combination nicotine replacement therapy (NRT). Varenicline is a partial agonist at the α4β2\alpha_4\beta_2 nicotinic acetylcholine receptor, relieving withdrawal symptoms while blocking the rewarding effects of nicotine. Large randomized trials have demonstrated that varenicline is highly effective for smoking cessation and is safe to use in patients with stable psychiatric conditions, including bipolar disorder, without a significant risk of mood destabilization.

Step-by-Step Solution

1
Identify the primary diagnosis and the patient's goal.
The patient has severe Tobacco Use Disorder and wants to quit smoking using an oral prescription medication.
Establishes the clinical objective and guides the choice of pharmacotherapy.
2
Review the patient's past treatment trials.
The patient has already failed combination nicotine replacement therapy (patches and gum).
Eliminates NRT as the optimal next step, indicating a need to step up to first-line non-nicotine oral therapies.
3
Evaluate the patient's comorbidities and medication safety.
The patient has bipolar I disorder. Oral options like bupropion act as antidepressants and can precipitate mania. Varenicline does not have this risk.
Ensures the selected pharmacotherapy does not destabilize the patient's underlying psychiatric condition.

Key Concept

Management of Tobacco Use Disorder in patients with comorbid Bipolar Disorder involves utilizing varenicline while avoiding antidepressant-based cessation therapies (such as bupropion) that carry a risk of precipitating a manic episode.
Question 42Question →

A 27-year-old woman is brought to the psychiatric clinic by her husband due to bizarre behavior. She gave birth to her first child 9 weeks ago via an uncomplicated vaginal delivery. Her husband reports that exactly 2 weeks after the delivery, the patient began claiming that the television was transmitting coded messages from a secret government agency regarding her infant's "chosen destiny." Shortly thereafter, she started hearing two unfamiliar men's voices debating whether she is a suitable mother. These symptoms have been present consistently every day since they started. The patient has no prior psychiatric history and takes no medications. Her husband has taken over all infant care, as the patient is frequently preoccupied with the voices and appears emotionally detached. During the interview, the patient's affect is blunted and she avoids eye contact. She denies feeling sad, hopeless, or overly energetic. Her husband confirms her sleep and appetite have remained normal throughout this period. Medical workup, including a comprehensive metabolic panel and thyroid-stimulating hormone, is unremarkable. Urine toxicology screen is negative. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophreniform disorder

Answer

Schizophreniform disorder
The correct diagnosis is schizophreniform disorder. This patient presents with acute onset of delusions, auditory hallucinations, and negative symptoms causing significant functional impairment. The critical differentiating factor is the timeline. Her symptoms began 2 weeks postpartum and she is now 9 weeks postpartum, meaning the total duration of the disturbance is exactly 7 weeks. In the absence of a major mood episode or substance use, a psychotic episode lasting at least 1 month but less than 6 months meets the DSM-5 diagnostic criteria for schizophreniform disorder.

Step-by-Step Solution

1
Calculate the exact duration of the patient's psychotic symptoms.
The patient gave birth 9 weeks ago, and symptoms started 2 weeks postpartum. Therefore, the symptoms have been present for exactly 7 weeks (approximately 1.5 months).
Duration is the primary differentiating factor among primary psychotic disorders.
2
Identify the primary psychiatric symptoms present.
The patient has bizarre delusions, auditory hallucinations, and negative symptoms (blunted affect), which meet Criterion A for the schizophrenia spectrum.
Establishing the presence of active-phase psychotic symptoms is necessary to enter the schizophrenia spectrum diagnostic algorithm.
3
Evaluate for the presence of concurrent mood symptoms or substance use.
The patient denies depressive or manic symptoms, has normal neurovegetative signs, and has negative toxicology and normal medical workup.
This rules out schizoaffective disorder, major depressive disorder with psychotic features, and substance/medication-induced psychotic disorder.
4
Apply the duration criteria to the isolated psychotic presentation.
The duration of 7 weeks is greater than 1 month but less than 6 months.
This timeline specifically establishes the diagnosis of schizophreniform disorder, excluding brief psychotic disorder (<1 month) and schizophrenia (>6 months).

Key Concept

The diagnosis of primary psychotic disorders relies heavily on symptom duration: Brief psychotic disorder lasts <1 month, schizophreniform disorder lasts between 1 and 6 months, and schizophrenia requires continuous signs of disturbance for ≥6 months.
Question 43Question →

Match each clinical vignette involving a legal or ethical dilemma in a psychiatric setting with the most appropriate next step in management or mandated action.

Click a left item, then click its matching right item

Items

An adult male patient evaluated in the emergency department reveals a detailed plan to overdose on stockpiled medications tonight, while adamantly declining voluntary admission.
A young adult admitted for substance-induced psychosis is actively attempting to strike nurses and aggressively pulling at intravenous lines, failing to respond to verbal de-escalation.
During an outpatient session, a middle-aged client discloses a specific, imminent plan to fatally assault his ex-wife's new partner, identifying the partner by name.
A female patient with a history of chronic schizophrenia and mild persecutory delusions clearly articulates the clinical risks of untreated hyperlipidemia but declines a routine screening blood draw.

Matches

Show answer & explanation

Answer

The correct pairings map the actively suicidal patient to an involuntary hold, the actively violent patient to emergency pharmacological restraint, the homicidal patient to breaching confidentiality (Tarasoff), and the clinically stable patient with schizophrenia to respecting autonomy.
Each psychiatric scenario requires a specific legal and ethical threshold to be met. Imminent self-harm dictates an involuntary hold; imminent violence dictates emergency chemical restraint; specific threats to others dictate a breach of confidentiality; and intact capacity despite mental illness dictates respect for autonomy.

Step-by-Step Solution

1
Analyze the scenario involving active suicidality and refusal of voluntary care.
Matches with initiating an involuntary psychiatric hospitalization.
Imminent risk of self-harm temporarily overrides patient autonomy, requiring involuntary admission to ensure safety.
2
Analyze the scenario with active violence on the medical unit.
Matches with administering emergency pharmacological restraint.
Immediate physical danger to staff and the failure of less restrictive measures permits the administration of emergency medication over the patient's objection.
3
Analyze the scenario involving a specific threat to a named third party.
Matches with breaching confidentiality to warn the victim.
The duty to protect/warn legally supersedes standard patient confidentiality protections when there is a credible, specific threat to an identifiable victim.
4
Analyze the scenario with a schizophrenic patient refusing a routine blood draw.
Matches with accepting the refusal of medical care.
The patient demonstrates intact capacity for this specific medical decision by articulating the risks; underlying psychosis does not strip away her right to refuse care.

Key Concept

Ethical principles in psychiatric emergencies: Involuntary holds, emergency consent, duty to protect, and decision-making capacity.
Question 44Question →

Match each patient's clinical presentation with the most likely corresponding substance intoxication or withdrawal syndrome.

Click a left item, then click its matching right item

Items

Phencyclidine (PCP) Intoxication
Opioid Withdrawal
Cocaine Intoxication
Benzodiazepine Withdrawal

Matches

Show answer & explanation

Answer

Phencyclidine (PCP) Intoxication matches with extreme agitation and rotatory nystagmus; Opioid Withdrawal matches with yawning, lacrimation, and piloerection; Cocaine Intoxication matches with acute chest pressure and nasal erythema; Benzodiazepine Withdrawal matches with delayed seizures and tremors after losing prescription access.
Each substance produces a highly specific toxidrome or withdrawal pattern that allows for clinical diagnosis: PCP uniquely causes nystagmus and analgesia, cocaine causes profound sympathetic overdrive with localized nasal findings, opioid withdrawal mimics a severe viral illness with pathognomonic piloerection, and benzodiazepine withdrawal presents as life-threatening delayed CNS excitation.

Step-by-Step Solution

1
Analyze the presentation with myalgias, yawning, lacrimation, and piloerection.
Identify this as an influenza-like syndrome characteristic of Opioid Withdrawal.
These specific signs (especially yawning and piloerection) are hallmark physiological responses to the absence of exogenous opioids.
2
Analyze the presentation with chest pressure, tachycardia, diaphoresis, and nasal erythema.
Identify this as Cocaine Intoxication.
Cocaine acts as a potent sympathomimetic causing coronary vasospasm and myocardial ischemia, and its insufflation damages nasal mucosa.
3
Analyze the presentation with delayed seizures, tremors, and autonomic hyperactivity after discontinuing medications.
Identify this as Benzodiazepine Withdrawal.
Stopping GABA-A modulators abruptly removes inhibitory tone, leading to severe excitatory rebound including delirium and seizures.
4
Analyze the presentation with extreme agitation, decreased pain perception, and rotatory nystagmus.
Identify this as Phencyclidine (PCP) Intoxication.
Rotatory nystagmus combined with violent behavior and analgesia is the classic triad for PCP toxicity.

Key Concept

Clinical recognition of distinctive substance toxidromes and withdrawal syndromes
Question 45Question →

An unmedicated 28-year-old male graphic designer comes to the physician seeking help for debilitating 'panic spells'. He states that over the last four months, he has suffered six unexpected episodes of overwhelming fear, pounding heart, diaphoresis, and a feeling that he might die. These episodes reach maximum intensity within a few minutes. He has become increasingly fearful of experiencing another attack and now refuses to ride the city bus to his office.

Physical examination, electrocardiography, and laboratory studies (including thyroid function) show no abnormalities.

During the clinical interview, the patient discloses a history of severe depression in his early twenties. Furthermore, at age 24, he experienced a distinct three-week period characterized by a markedly decreased need for sleep, pressured speech, and grandiose delusions that he was a famous inventor, which resulted in a psychiatric hospitalization. He has not taken any prescribed medications for the past two years.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate cognitive-behavioral therapy

Answer

Initiate cognitive-behavioral therapy
The correct intervention is to initiate cognitive-behavioral therapy (CBT). This patient currently meets the criteria for Panic Disorder with Agoraphobia. While selective serotonin reuptake inhibitors (SSRIs) are generally the pharmacological treatment of choice for panic disorder, this patient has a clear history of Bipolar I disorder (evidenced by his prior manic episode with grandiose delusions). Initiating SSRI monotherapy in an unmedicated patient with Bipolar I disorder carries a significant risk of precipitating a manic switch. CBT is an equally effective, first-line evidence-based treatment for panic disorder that avoids pharmacological risks and is the safest, most appropriate next step.

Step-by-Step Solution

1
Diagnose the patient's current primary presenting problem.
The recurrent, unexpected attacks of fear with autonomic arousal, followed by avoidance behavior (not riding the bus), point to Panic Disorder with Agoraphobia.
Establishing the current diagnosis dictates the framework for indicated therapies.
2
Analyze the past psychiatric history for relevant comorbidities.
The history of a distinct period of decreased sleep, pressured speech, and grandiose delusions requiring hospitalization indicates a past manic episode with psychotic features, securing a diagnosis of Bipolar I Disorder.
Comorbidities, especially Bipolar Disorder, drastically alter pharmacological management protocols for anxiety disorders.
3
Evaluate treatment options based on both the current diagnosis and the comorbid risk factors.
Standard pharmacotherapy for panic disorder (SSRI monotherapy) must be avoided to prevent a medication-induced manic switch. Therefore, a non-pharmacological first-line approach is safest.
Maximizing therapeutic benefit while minimizing the risk of severe adverse events (like inducing mania) is the core principle of psychiatric management.

Key Concept

Management of Anxiety Disorders in Bipolar Patients
Question 46Question →

Match each clinical presentation to the most accurate sleep-wake disorder diagnosis.

Click a left item, then click its matching right item

Items

Narcolepsy Type 1
REM Sleep Behavior Disorder
Non-REM Sleep Arousal Disorder
Delayed Sleep-Wake Phase Disorder

Matches

Show answer & explanation

Answer

Narcolepsy Type 1 matches with the young woman experiencing cataplexy; REM Sleep Behavior Disorder matches with the older man enacting vivid dreams; Non-REM Sleep Arousal Disorder matches with the young child having sleep terrors with amnesia; and Delayed Sleep-Wake Phase Disorder matches with the college student exhibiting a shifted sleep schedule.
Each clinical vignette provides pathognomonic features for specific sleep-wake disorders. Narcolepsy type 1 is defined by cataplexy and sleepiness. REM sleep behavior disorder is characterized by dream enactment due to absent REM atonia. Non-REM sleep arousal disorder (sleep terrors) presents with profound autonomic arousal and amnesia for the episode. Delayed sleep-wake phase disorder involves a shifted but otherwise normal circadian sleep pattern.

Step-by-Step Solution

1
Analyze the young woman's presentation.
She presents with chronic sleepiness and emotion-triggered muscle weakness.
These are the classic signs of hypersomnolence and cataplexy, pointing directly to Narcolepsy Type 1.
2
Evaluate the older man's nocturnal behaviors.
He exhibits physical actions during sleep and vividly remembers dreaming.
This indicates a failure of the normal muscle paralysis (atonia) that should occur during REM sleep, diagnosing REM Sleep Behavior Disorder.
3
Assess the pediatric patient's nighttime awakenings.
The child wakes up terrified, cannot be consoled, and does not remember the event.
These features distinguish Non-REM sleep terrors (occurring in slow-wave sleep without dream recall) from typical nightmares.
4
Review the college student's sleep schedule.
The patient has a severely delayed sleep onset but normal sleep duration when allowed to sleep in.
This pattern is a circadian rhythm misalignment known as Delayed Sleep-Wake Phase Disorder.

Key Concept

Clinical differentiation of major sleep-wake disorders based on symptomatology, sleep cycle stage, and patient demographics.
Question 47Question →

Match each pharmacotherapy used in the treatment of substance-related and addictive disorders to its primary mechanism of action, key clinical consideration, or contraindication.

Click a left item, then click its matching right item

Items

Acamprosate
Varenicline
Buprenorphine
Naltrexone
Methadone

Matches

Show answer & explanation

Answer

Acamprosate matches with the renal contraindication; Varenicline matches with the nicotinic partial agonist mechanism and vivid dreams; Buprenorphine matches with the high-affinity partial agonist mechanism capable of precipitating withdrawal; Naltrexone matches with the competitive antagonist requiring opioid abstinence; Methadone matches with the full agonist requiring QTc monitoring.
Each major pharmacotherapy for substance use disorders possesses distinct receptor interactions, adverse effect profiles, and metabolic pathways that govern clinical decision-making. Acamprosate is unique in being renally cleared, avoiding hepatotoxicity. Varenicline targets nicotinic receptors to reduce cravings but causes vivid dreams. Buprenorphine's high receptor affinity allows it to displace full agonists, which can precipitate withdrawal. Naltrexone completely blocks opioid receptors and requires a completely opioid-free system to prevent severe withdrawal. Methadone acts as a full agonist and carries a specific risk for QTc prolongation, necessitating cardiac monitoring.

Step-by-Step Solution

1
Identify the mechanism and primary clearance route for Acamprosate.
Matched with NMDA modulation and renal contraindication.
Acamprosate is uniquely renally excreted among alcohol use disorder medications, making severe renal impairment its primary contraindication.
2
Identify the mechanism and common side effects of Varenicline.
Matched with nicotinic partial agonism, nausea, and abnormal dreams.
Varenicline specifically targets nicotinic receptors for tobacco use disorder and characteristically causes vivid dreams.
3
Differentiate the opioid use disorder medications based on receptor affinity and intrinsic activity.
Buprenorphine matched with partial agonism and precipitated withdrawal risk.
Buprenorphine's high affinity but partial agonism causes it to displace full agonists, precipitating withdrawal if patients are not already in mild withdrawal.
4
Identify the medication requiring prolonged abstinence prior to initiation.
Naltrexone matched with competitive antagonism requiring 7-14 days of abstinence.
As a pure antagonist, naltrexone will induce severe withdrawal if any opioids remain in the patient's system.
5
Identify the major safety monitoring requirement for Methadone.
Matched with full agonism and QTc prolongation risk.
Methadone is unique among these agents for its significant risk of dose-dependent QTc prolongation, requiring baseline and periodic ECGs.

Key Concept

Pharmacotherapy for Substance-Related and Addictive Disorders
Question 48Question →

A psychiatry care team is reviewing the management plans for four distinct patients presenting with psychotic spectrum symptoms. Match each patient's specific clinical scenario to the most appropriate next step in pharmacological management.

Click a left item, then click its matching right item

Items

A 32-year-old with chronic perceptual disturbances who has shown no clinical improvement despite two separate 8-week trials of oral olanzapine and oral aripiprazole at maximum tolerated doses.
A 68-year-old with idiopathic Parkinson disease who recently developed distressing visual hallucinations, which have persisted despite a cautious, neurologist-supervised reduction of carbidopa-levodopa.
A 22-year-old who experienced a first episode of psychotic symptoms lasting exactly 18 days before achieving full remission. He is currently asymptomatic and inquiring about the duration of maintenance therapy.
A 29-year-old brought to the emergency department displaying severe, escalating psychomotor agitation, threatening staff, and actively refusing any oral medications.

Matches

Show answer & explanation

Answer

The optimal management strategies involve matching treatment resistance with clozapine, Parkinson disease psychosis with pimavanserin or quetiapine, a brief psychotic episode with a short 1-to-3-month maintenance followed by a taper, and acute uncooperative agitation with intramuscular haloperidol.
Each clinical scenario presents a specific indication for a specialized pharmacological approach. Treatment-resistant psychosis (failure of at least two antipsychotic trials) uniquely requires clozapine. Psychosis secondary to Parkinson disease requires antipsychotics with weak D2 antagonism (pimavanserin, quetiapine) to circumvent worsening motor symptoms. A brief psychotic episode (lasting less than 1 month) is treated with a short course of maintenance therapy followed by a taper, rather than lifelong treatment. Finally, acute agitation in an uncooperative emergency patient necessitates short-acting intramuscular medications to ensure rapid staff and patient safety.

Step-by-Step Solution

1
Analyze the first clinical vignette regarding the 32-year-old patient.
Identify that failing two 8-week trials of antipsychotics meets the criteria for treatment-resistant psychosis.
Recognizing treatment resistance dictates the transition to the most effective agent for refractory cases, clozapine.
2
Evaluate the 68-year-old patient with Parkinson disease.
Determine that the patient requires an antipsychotic that will not exacerbate underlying parkinsonism.
Standard high-potency D2 antagonists would worsen motor function; therefore, atypical agents with low D2 affinity like quetiapine or pimavanserin are indicated.
3
Assess the symptom timeline of the 22-year-old patient.
Note the 18-day duration of symptoms, placing the diagnosis strictly under 1 month, indicating a brief psychotic episode.
Accurately diagnosing based on the timeline prevents inappropriate lifelong prescribing, guiding the decision toward a short 1-to-3-month maintenance taper.
4
Address the 29-year-old patient in the emergency setting.
Identify the immediate threat of acute agitation combined with medication refusal.
Ensuring safety requires overriding the oral route with a rapid-acting intramuscular formulation.

Key Concept

Tailored psychopharmacological management of psychotic disorders based on clinical presentation, timeline, comorbidities, and treatment history.
Estimated Time:1m 30s
Question 49Question →

A 37-year-old man comes to the psychiatrist complaining of feeling "completely empty" for the past 2 months. He reports that he has lost interest in his architectural work, which he usually loves, and struggles to get out of bed before noon. His appetite has decreased, leading to an 8-lb (3.6-kg) weight loss. He expresses intense guilt over a minor calculation mistake he made on a project a year ago. A review of his past medical records reveals an emergency department visit 3 years ago for acute agitation. During that visit, he was speaking so quickly he was difficult to understand, claimed he had discovered the secret to limitless energy, and had not slept in 5 days. He was stabilized on a medication that he subsequently stopped taking because he felt it blunted his creativity. His vital signs and physical examination today are unremarkable. Which of the following is the most appropriate next step in the pharmacologic management of this patient's current symptoms?

Show answer & explanation

Answer: Lurasidone therapy

Answer

Lurasidone therapy
The correct answer is lurasidone therapy. This patient is currently experiencing a major depressive episode, but his history of a distinct period of severe agitation, pressured speech, grandiosity, and decreased need for sleep lasting 5 days (which required emergency stabilization) meets the criteria for a past manic episode. Therefore, his correct diagnosis is bipolar I disorder, currently in a depressed phase (bipolar depression). The first-line pharmacological treatments for bipolar depression include lurasidone, quetiapine, and the olanzapine-fluoxetine combination. Lurasidone is a second-generation (atypical) antipsychotic that effectively treats bipolar depression without the risk of inducing a manic switch.

Step-by-Step Solution

1
Analyze the current clinical presentation.
The patient has a 2-month history of depressed mood, anhedonia, neurovegetative symptoms (weight loss, hypersomnia), and excessive guilt, indicating a major depressive episode.
Identifying the current affective state is the first step in establishing the phase of illness.
2
Evaluate the past psychiatric history.
The history of a distinct period of rapid speech, grandiosity, and decreased need for sleep lasting 5 days (requiring emergency intervention) indicates a past manic episode.
A history of mania changes the primary diagnosis from major depressive disorder (unipolar) to bipolar I disorder.
3
Determine the most appropriate treatment for bipolar depression.
Lurasidone is selected as it is an FDA-approved, first-line atypical antipsychotic for acute bipolar depression.
Antidepressant monotherapy must be avoided in bipolar I disorder due to the severe risk of precipitating a manic switch.

Key Concept

Management of Bipolar Depression
Question 50Question →

Campus security brings a 19-year-old male university student to the emergency department after he was found destroying furniture in his dormitory. The student's friends report that he went to an off-campus warehouse party three days ago and has been awake ever since. He has been barricaded in his room, loudly claiming that hidden cameras are broadcasting his thoughts. Vital signs show a temperature of 38.6°C (101.5°F), blood pressure of 172/105 mmHg, and heart rate of 138/min. Physical examination reveals profound diaphoresis, mydriasis, and psychomotor agitation. There is no horizontal or vertical nystagmus, and muscle tone is normal. Routine urine drug immunoassay is negative for all tested substances. The patient requires multiple doses of chemical restraints over the next four days to manage ongoing severe combativeness and hallucinations. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Synthetic cathinone intoxication

Answer

Synthetic cathinone intoxication
The patient's presentation of severe psychosis, extreme agitation, and profound sympathetic overactivity (tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis) is characteristic of sympathomimetic intoxication. While cocaine and amphetamines present similarly, their duration of action is much shorter (clearing within hours). In contrast, synthetic cathinones (often sold as 'bath salts') are structurally related to amphetamines but can cause exceptionally prolonged delirium and psychosis that routinely last for days to over a week, necessitating prolonged chemical restraints. Furthermore, unlike cocaine, opioids, and PCP, synthetic cathinones are not detected by routine urine drug immunoassays. The combination of prolonged sympathomimetic toxicity, extreme combativeness, and a negative routine toxicology screen makes synthetic cathinone intoxication the most likely diagnosis.

Step-by-Step Solution

1
Analyze the clinical presentation.
The patient exhibits severe acute psychosis, extreme agitation, and profound sympathetic overactivity (tachycardia, hypertension, hyperthermia, diaphoresis, mydriasis).
Identifying the toxidrome helps narrow down the etiology to sympathomimetic agents rather than primary psychiatric disorders.
2
Evaluate the timeline and diagnostic findings.
The symptoms have lasted for days, and the routine urine drug screen is negative.
This rules out shorter-acting substances like cocaine and typical amphetamines, and highlights a substance not detected on standard assays.
3
Synthesize the data to identify the specific substance.
Prolonged sympathomimetic toxicity with delirium/psychosis and a negative drug screen is characteristic of synthetic cathinones.
Synthetic cathinones evade routine detection and cause exceptionally long-lasting clinical effects.

Key Concept

Synthetic cathinones ('bath salts') are amphetamine analogs that cause prolonged sympathetic overactivity and extreme psychosis/agitation, typically lasting days to a week, and are not detected on standard urine drug screens.
Question 51Question →

During a routine wellness visit, the parents of a 9-year-old boy express deep concern regarding his increasingly difficult behavior. For the past 9 months, he has consistently refused to follow household rules and argues excessively with adults. The parents note that he deliberately annoys his younger sister and quickly blames her whenever he gets into trouble. A written report from his third-grade teacher describes identical defiant behavior during class, noting that he often loses his temper when asked to transition between activities. Despite these challenges, he has never engaged in physical fights, property destruction, or theft. His sleep patterns and appetite are normal, and he maintains friendships with a small group of neighborhood peers. His physical examination is unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Parent management training

Answer

Parent management training
The correct intervention is parent management training. This patient's presentation of argumentative and defiant behavior, blaming others, and deliberately annoying people for at least 6 months across multiple settings (home and school) is characteristic of Oppositional Defiant Disorder (ODD). Importantly, he lacks the more severe rule-breaking behaviors seen in Conduct Disorder (e.g., cruelty to animals, theft, destruction of property). The cornerstone of treatment for ODD is psychological intervention, specifically parent management training, which teaches caregivers how to implement consistent limit-setting, positive reinforcement, and effective communication strategies. Pharmacotherapy is generally reserved for treating comorbid conditions (like ADHD) rather than ODD itself.

Step-by-Step Solution

1
Analyze the clinical presentation and duration of symptoms.
The patient exhibits argumentative behavior, defiance, vindictiveness, and deliberately annoys others for 9 months across two settings (home and school).
Establishing the core symptom cluster and timeframe is required to differentiate psychiatric behavioral disorders.
2
Differentiate from similar disruptive behavior disorders.
The absence of physical aggression, property destruction, and theft rules out Conduct Disorder. The absence of primary impulsivity/hyperactivity makes ADHD less likely as the core diagnosis.
Behavioral disorders in children exist on a spectrum, and severity of rule-breaking dictates the diagnosis.
3
Determine the first-line management for the identified diagnosis (Oppositional Defiant Disorder).
Behavioral interventions, specifically targeting family dynamics, are the standard of care.
Pharmacotherapy is not first-line for ODD unless there is a specific comorbidity like ADHD.

Key Concept

Oppositional Defiant Disorder (ODD) Diagnosis and Management
Question 52Question →

Match each patient's clinical presentation of a psychotropic adverse effect with the medication most likely responsible.

Click a left item, then click its matching right item

Items

A 24-year-old woman develops a painful, blistering rash with oral mucosal ulcerations two weeks after initiating a new medication for bipolar depression.
A 42-year-old man exhibits sudden, sustained neck muscle contraction and upward eye deviation hours after receiving an intramuscular injection for severe agitation.
A 55-year-old man with bipolar I disorder presents with excessive thirst and frequent urination; laboratory tests show a low urine osmolality that remains unchanged after desmopressin administration.
A 35-year-old woman develops a resting tremor, slowed movements, and cogwheel rigidity several weeks after starting a medication for a recent psychotic episode.
A 29-year-old woman experiences severe dizziness, flu-like symptoms, and sensory disturbances described as 'brain zaps' 48 hours after abruptly discontinuing her daily medication for generalized anxiety disorder.

Matches

Show answer & explanation

Answer

Lamotrigine causes Stevens-Johnson syndrome; Haloperidol causes acute dystonia; Lithium causes nephrogenic diabetes insipidus; Risperidone causes drug-induced parkinsonism; Paroxetine causes antidepressant discontinuation syndrome.
Each patient presentation highlights a classic and severe side effect unique to or highly characteristic of a specific psychotropic medication. Recognizing these toxidromes is critical for safe medication management and rapid intervention.

Step-by-Step Solution

1
Identify the underlying diagnosis for the specific adverse effect described in each patient presentation.
The presentations describe Stevens-Johnson syndrome (rash with mucosal involvement), acute dystonia (torticollis/oculogyric crisis), nephrogenic diabetes insipidus (polyuria unresponsive to desmopressin), drug-induced parkinsonism (tremor/rigidity), and discontinuation syndrome (flu-like symptoms and 'brain zaps').
Accurately recognizing the toxidrome or side effect is the necessary first step to matching it with the offending medication.
2
Correlate each identified adverse effect with the psychotropic medication known to cause it based on its pharmacologic profile.
Stevens-Johnson syndrome is matched with Lamotrigine. Acute dystonia is matched with Haloperidol. Nephrogenic diabetes insipidus is matched with Lithium. Drug-induced parkinsonism is matched with Risperidone. Discontinuation syndrome is matched with Paroxetine.
Linking the clinical presentation to the offending agent demonstrates mastery of psychopharmacologic side effect profiles.

Key Concept

Psychotropic medication adverse effects and toxicity syndromes
Question 53Question →

A 35-year-old male construction worker is brought to the emergency department by his wife due to sudden-onset severe agitation, fever, and muscle stiffness. His medical history is significant for major depressive disorder, for which he has been taking sertraline for the past 2 years. Two days ago, the patient underwent a complex root canal procedure and was prescribed a short course of a centrally acting analgesic. On physical examination, his temperature is 39.4°C (102.9°F), blood pressure is 165/100 mmHg, and heart rate is 118/min. He is diaphoretic, flushed, and noticeably disoriented. Neurologic examination reveals bilateral ankle clonus, marked shivering, and generalized hyperreflexia that is most prominent in the lower extremities. Which of the following describes the mechanism of action of the analgesic that most likely precipitated this patient's current condition?

Show answer & explanation

Answer: Inhibition of presynaptic serotonin and norepinephrine reuptake

Answer

The correct answer is the inhibition of presynaptic serotonin and norepinephrine reuptake, representing the mechanism of tramadol.
The patient's clinical presentation of altered mental status, autonomic instability, and prominent neuromuscular hyperactivity (hyperreflexia, ankle clonus) in the setting of ongoing sertraline therapy is highly characteristic of serotonin syndrome. The precipitating event was the addition of a centrally acting analgesic. Tramadol is a unique analgesic because, in addition to acting as a weak mu-opioid receptor agonist, it inhibits the presynaptic reuptake of serotonin and norepinephrine. When combined with an SSRI like sertraline, tramadol can lead to excessive central serotonergic neurotransmission, precipitating life-threatening serotonin syndrome.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits autonomic instability (fever, hypertension, tachycardia, diaphoresis), altered mental status (agitation, disorientation), and neuromuscular hyperactivity (hyperreflexia, bilateral ankle clonus).
Identifying the toxidrome is the first step in determining the underlying etiology.
2
Correlate the toxidrome with the patient's medication history.
The clinical picture strongly indicates serotonin syndrome, especially given the patient's baseline use of an SSRI (sertraline).
Serotonin syndrome is a life-threatening condition caused by excessive serotonergic activity in the central nervous system.
3
Identify the precipitating medication.
The patient recently started a centrally acting analgesic for a dental procedure. Among analgesics, tramadol is known to trigger serotonin syndrome when combined with SSRIs.
Tramadol has unique serotonergic properties compared to traditional analgesics.
4
Recall the pharmacologic mechanism of the precipitant.
Tramadol acts as a weak mu-opioid receptor agonist and also inhibits the reuptake of serotonin and norepinephrine.
Answering the question requires matching the identified drug (tramadol) with its precise mechanism of action.

Key Concept

Serotonin syndrome can be precipitated by combining SSRIs with analgesics that have serotonergic activity, such as tramadol. Recognizing tramadol's dual mechanism of action (mu-opioid agonism and SNRI activity) is critical to avoiding this dangerous drug-drug interaction.
Question 54Question →

A 26-year-old woman presents to the psychiatric clinic accompanied by her husband. She gave birth to her first child 3 months ago. Over the past month, she has been experiencing recurrent, terrifying mental images of deliberately dropping her infant down the staircase. She finds these images deeply disturbing and recognizes them as products of her own mind. She has no desire to harm her child. To cope, she absolutely refuses to carry the infant near any stairs and repeatedly asks her husband to confirm she is a capable mother, occupying several hours of their day. Her psychiatric history is significant for bipolar II disorder, currently well-controlled on lithium. At age 21, following a severe stressor, she experienced auditory hallucinations that lasted for 2 weeks and resolved completely without long-term medication. Currently, in addition to lithium, she takes over-the-counter St. John's wort for mild fatigue. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Engage the patient in specialized psychotherapy focusing on symptom habituation

Answer

Engage the patient in specialized psychotherapy focusing on symptom habituation
The patient's presentation of distressing, ego-dystonic intrusive images and subsequent avoidance and reassurance-seeking is diagnostic of Obsessive-Compulsive Disorder (OCD). First-line treatments for OCD include serotonergic antidepressants and specialized psychotherapy, specifically Exposure and Response Prevention (ERP). Because this patient has a confirmed history of bipolar II disorder, introducing an antidepressant monotherapy carries a significant risk of precipitating a hypomanic or manic episode. Therefore, initiating symptom-focused psychotherapy (which focuses on habituation to the feared stimulus without performing the compulsion) is the safest and most appropriate first-line intervention.

Step-by-Step Solution

1
Diagnose the current acute presentation based on clinical symptoms.
The patient has ego-dystonic intrusive thoughts (obsessions) and performs avoidance/reassurance-seeking behaviors (compulsions). This confirms Obsessive-Compulsive Disorder (OCD), specifically with postpartum onset.
Accurate diagnosis is required before selecting treatment. Her insight is intact, ruling out psychosis.
2
Evaluate the patient's psychiatric history and current medication profile.
History of Bipolar II disorder (on lithium), a remote 2-week Brief Psychotic Disorder, and current use of St. John's wort.
Comorbidities and supplements severely restrict pharmacological options in psychiatric management.
3
Select the safest first-line treatment for OCD balancing efficacy and contraindications.
While SSRIs are typically first-line, antidepressant monotherapy is contraindicated due to her bipolar history. St. John's wort precludes MAOIs. Therefore, specialized psychotherapy (Exposure and Response Prevention) is the safest and most effective initial step.
Psychotherapy provides robust treatment for OCD without the risk of precipitating a manic switch or causing fatal drug interactions.

Key Concept

Management of Obsessive-Compulsive Disorder in the context of Bipolar Disorder comorbidities
Estimated Time:1m 30s
Question 55Question →

Match each patient's clinical scenario and specific medication requirement with the most appropriate second-generation antipsychotic.

Click a left item, then click its matching right item

Items

A 24-year-old man with schizophrenia is started on an antipsychotic that acts as a dopamine D2 partial agonist. Shortly after, he develops severe inner restlessness and an inability to sit still.
A 33-year-old woman with acute schizophrenia is prescribed an antipsychotic that must be taken with a 500-calorie meal for adequate absorption. A baseline electrocardiogram is ordered due to a known dose-dependent risk of QTc prolongation.
A 45-year-old man with schizoaffective disorder is prescribed a medication formulated specifically for sublingual administration to bypass extensive first-pass hepatic metabolism. He is told not to eat or drink for 10 minutes after dosing.
A 30-year-old woman with bipolar depression is prescribed an agent with potent 5-HT7 receptor antagonism. She is instructed to take the medication with a meal of at least 350 calories to ensure adequate clinical efficacy.

Matches

Show answer & explanation

Answer

The patient with akathisia and D2 partial agonism matches with Aripiprazole. The patient requiring a 500-calorie meal and an ECG for QTc prolongation matches with Ziprasidone. The patient requiring sublingual administration to bypass first-pass metabolism matches with Asenapine. The patient with bipolar depression requiring a 350-calorie meal matches with Lurasidone.
Each antipsychotic possesses distinct pharmacokinetic and pharmacodynamic properties that dictate its administration. Aripiprazole is a partial D2 agonist causing akathisia. Ziprasidone requires a 500-calorie meal and can prolong the QTc interval. Asenapine must be taken sublingually to avoid first-pass metabolism. Lurasidone requires a 350-calorie meal and acts at 5-HT7 receptors for treating bipolar depression.

Step-by-Step Solution

1
Identify the antipsychotic that acts as a D2 partial agonist and is strongly associated with akathisia.
Aripiprazole is the classic D2 partial agonist, which fundamentally alters its side effect profile, making akathisia highly prevalent while reducing hyperprolactinemia.
Recognizing aripiprazole's unique partial agonism is essential for differentiating its clinical effects from full antagonists.
2
Analyze the specific administration requirements and cardiac risks associated with the second vignette.
Ziprasidone requires a 500-calorie meal for optimal systemic absorption and carries a prominent warning for dose-dependent QTc prolongation.
Matching food requirements and specific toxicities (QTc prolongation) points directly to ziprasidone.
3
Determine the pharmacokinetic rationale for a sublingual atypical antipsychotic.
Asenapine is uniquely formulated for sublingual delivery because extensive first-pass hepatic metabolism renders the oral swallowed route ineffective.
This specific delivery mechanism and the instruction to avoid food/water for 10 minutes post-dose is pathognomonic for asenapine.
4
Evaluate the receptor profile and clinical indications of the remaining medication.
Lurasidone requires a 350-calorie meal, acts as a potent 5-HT7 antagonist, and is FDA-approved for bipolar depression without causing significant metabolic syndrome.
Synthesizing the exact caloric requirement with the bipolar depression indication confirms lurasidone.

Key Concept

Pharmacokinetic and pharmacodynamic profiles of second-generation antipsychotics
Question 56Question →

Pair the following acute clinical presentations with their most likely underlying substance-related diagnosis.

Click a left item, then click its matching right item

Items

Profound agitation, horizontal and vertical nystagmus, diminished response to pain, and significant hypertension.
Yawning, lacrimation, piloerection, diaphoresis, along with diffuse myalgias and abdominal cramping.
Marked tachycardia, pupillary dilation, nasal mucosal erythema, and sensations of insects crawling under the skin.
Fluctuating consciousness, visual hallucinations, coarse tremors, and profound autonomic instability developing three days after hospital admission.
Slurred speech, ataxia, and mild cognitive impairment with normal vital signs and no significant respiratory depression.

Matches

Show answer & explanation

Answer

The correct pairings accurately match the specific toxidrome or withdrawal syndrome based on classic physical exam findings and symptom timelines: the presentation with multidirectional nystagmus pairs with Phencyclidine (PCP) intoxication; the presentation with yawning and piloerection pairs with Opioid withdrawal; the presentation with formication and mucosal erythema pairs with Cocaine intoxication; the presentation with 72-hour delayed delirium pairs with Alcohol withdrawal delirium; and the presentation with ataxia and preserved vitals pairs with Benzodiazepine intoxication.
Each correct pairing links a distinct, high-yield clinical presentation with its corresponding substance-related syndrome. PCP intoxication is uniquely identified by nystagmus and analgesia; opioid withdrawal by yawning and piloerection; cocaine intoxication by sympathomimetic excess and formication; alcohol withdrawal delirium by its specific 48-96 hour onset with altered sensorium; and benzodiazepine intoxication by ataxia with preserved vital signs.

Step-by-Step Solution

1
Analyze each clinical vignette for pathognomonic physical exam findings or vital sign patterns.
Identified nystagmus in the first presentation, piloerection in the second, formication in the third, a 72-hour timeline in the fourth, and isolated CNS depression in the fifth.
Substance-related syndromes are best differentiated by unique combinations of autonomic signs and specific neurological findings.
2
Correlate sympathetic overactivity presentations with either stimulant intoxication or depressant withdrawal.
Differentiated cocaine intoxication from alcohol withdrawal based on the specific hospital admission timeline and the presence of delirium versus isolated sympathomimetic symptoms.
Both conditions cause tachycardia and agitation, but the temporal context and mental status examination are critical for diagnosis.
3
Evaluate CNS depression presentations.
Matched the final presentation to benzodiazepine intoxication due to the absence of severe respiratory depression or pinpoint pupils.
This helps rule out opioid intoxication, which would classically feature marked respiratory depression and miosis.

Key Concept

Clinical recognition of substance toxidromes and withdrawal syndromes based on autonomic nervous system signs, physical exam findings, and temporal relationships.
Estimated Time:2m 0s
Question 57Question →

Select the most appropriate initial pharmacological or procedural intervention for each of the following patients presenting with distinct clinical features of major depressive disorder.

Click a left item, then click its matching right item

Items

A 72-year-old man with a 4-week history of profound psychomotor retardation, somatic delusions that his internal organs are rotting, and complete refusal to consume any food or fluids.
A 55-year-old man presenting with a 3-month history of significant unintentional weight loss (9 kg), poor appetite, and severe initial and middle insomnia, leading to severe daytime fatigue.
A 48-year-old woman with a newly diagnosed major depressive episode who is also experiencing chronic, bilateral, burning stocking-glove paresthesias secondary to poorly controlled diabetes mellitus.
A 29-year-old woman with a 6-week history of major depressive disorder characterized by prominent lethargy and hypersomnia. She strongly emphasizes her desire to avoid any medication that may cause weight gain or sexual dysfunction.

Matches

Show answer & explanation

Answer

The clinical profiles map to interventions based on side effect profiles and comorbidities: the psychotic/refusing food patient matches with Electroconvulsive therapy; the insomniac/anorexic patient matches with Mirtazapine; the diabetic neuropathy patient matches with Duloxetine; and the lethargic patient avoiding sexual side effects matches with Bupropion.
Each patient's clinical vignette highlights specific indications for a particular therapy. The elderly man with psychotic depression and food refusal requires the rapid, life-saving response of electroconvulsive therapy. The man with severe insomnia and weight loss benefits from the sedating and appetite-stimulating effects of mirtazapine. The woman with diabetic neuropathy is best treated with duloxetine, an SNRI indicated for both conditions. The young woman with hypersomnia who wishes to avoid sexual dysfunction and weight gain is an ideal candidate for the activating NDRI bupropion.

Step-by-Step Solution

1
Analyze the 72-year-old man's presentation.
He has major depressive disorder with psychotic features (somatic delusions) and active food/fluid refusal.
Identifying life-threatening psychiatric emergencies is necessary to select rapid, definitive treatment over delayed pharmacological options.
2
Evaluate the 55-year-old man's vegetative symptoms.
He suffers primarily from weight loss and severe insomnia.
Antidepressants with sedating and appetite-stimulating side effects can simultaneously treat the depression and these specific target symptoms.
3
Identify the 48-year-old woman's comorbid medical condition.
She has painful diabetic neuropathy.
Using an agent that treats both depression and neuropathic pain reduces polypharmacy.
4
Consider the 29-year-old woman's specific aversions.
She is lethargic and wishes to avoid weight gain and sexual dysfunction.
Patient adherence is heavily influenced by side effects, so choosing an activating medication devoid of sexual/weight side effects is optimal.

Key Concept

Tailoring depression treatment based on patient-specific symptom clusters, comorbidities, and medication side-effect profiles.
Question 58Question →

Match each patient's clinical presentation of an adverse drug reaction to the psychotropic medication most likely responsible for their symptoms.

Click a left item, then click its matching right item

Items

A patient develops a severe inner sense of restlessness and an uncontrollable urge to pace two weeks after initiating treatment for schizophrenia.
A patient treated for bipolar disorder presents with increased thirst, frequent urination, and a fine bilateral hand tremor.
A patient treated for major depressive disorder and insomnia presents to the emergency department with a painful, prolonged erection lasting over four hours.
A patient receiving treatment for refractory psychotic symptoms presents with a fever, severe pharyngitis, and an absolute neutrophil count of 300/mm³.
A patient recently started on a mood stabilizer for bipolar depression develops a rapidly spreading, painful blistering rash with oral mucosal ulcerations.

Matches

Show answer & explanation

Answer

The correct matches are: Restlessness (akathisia) with Haloperidol; Polyuria and tremor with Lithium; Priapism with Trazodone; Agranulocytosis with Clozapine; and Blistering rash with Lamotrigine.
Each psychotropic medication has a distinct and highly tested adverse effect profile. Recognizing these specific toxicities is crucial for appropriate monitoring and safe psychopharmacologic management.

Step-by-Step Solution

1
Analyze the first presentation (severe restlessness and pacing).
Identify this as akathisia, a common extrapyramidal symptom.
Haloperidol, a high-potency first-generation antipsychotic, has the highest risk of extrapyramidal symptoms among the choices provided.
2
Analyze the second presentation (polyuria, polydipsia, fine tremor).
Identify these as classic signs of lithium use.
Lithium commonly causes nephrogenic diabetes insipidus and neurologic side effects like fine tremors.
3
Analyze the third presentation (prolonged, painful erection).
Identify this as priapism.
Trazodone is well-known for causing priapism due to its alpha-1 adrenergic blockade.
4
Analyze the fourth presentation (fever, sore throat, severe neutropenia).
Identify this as agranulocytosis.
Clozapine carries a black box warning for agranulocytosis and requires continuous absolute neutrophil count monitoring.
5
Analyze the fifth presentation (blistering rash with mucosal involvement).
Identify this as Stevens-Johnson syndrome.
Lamotrigine is associated with a severe, potentially life-threatening rash, especially during rapid dose escalation.

Key Concept

Adverse effect profiles of psychotropic medications
Question 59Question →

A 22-year-old woman is brought to the emergency department by her roommate due to increasingly bizarre behavior. The roommate reports that for the past 3 weeks, the patient has been locking herself in her room, claiming that foreign intelligence agents are transmitting messages into her brain through the electrical outlets. She has also been observed whispering to unseen entities and has stopped attending her college classes. The patient was previously healthy and highly functional until she experienced a sudden, traumatic breakup with her fiancé one month ago. She has no prior psychiatric or medical history. Vital signs are within normal limits, and a comprehensive physical examination is unremarkable. Urine toxicology screening is negative for illicit substances. The patient is admitted to the psychiatric unit and started on oral risperidone. Four days later, her psychotic symptoms completely resolve, and she is discharged with a full return to her baseline level of functioning. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Brief psychotic disorder

Answer

Brief psychotic disorder
The correct diagnosis is brief psychotic disorder because the patient experienced sudden onset of positive psychotic symptoms (delusions and hallucinations) that lasted between 1 day and 1 month (25 days total) before completely resolving, allowing her to return to her baseline functioning. This condition is frequently triggered by a severe psychological stressor, such as the sudden end of a major relationship.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient is experiencing positive psychotic symptoms, including delusions of persecution and auditory hallucinations, leading to functional impairment.
This establishes that the patient is suffering from a primary psychotic disorder, requiring differentiation among the schizophrenia spectrum disorders.
2
Determine the exact duration of the psychotic symptoms.
The symptoms began 3 weeks prior to presentation and resolved 4 days after admission, totaling 25 days.
Duration is the primary differentiator for acute psychotic presentations: <1 month (Brief psychotic disorder), 1-6 months (Schizophreniform disorder), >6 months (Schizophrenia).
3
Evaluate for the presence of concurrent mood episodes or specific features.
There is a precipitating stressor (breakup) but no evidence of a major depressive or manic episode. The patient returns to baseline functioning after symptom resolution.
This rules out schizoaffective disorder and supports the diagnosis of brief psychotic disorder, which is often stress-induced and followed by a full recovery.

Key Concept

The temporal criteria for diagnosing primary psychotic disorders are: Brief psychotic disorder (<1 month), Schizophreniform disorder (1 to 6 months), and Schizophrenia (>6 months).
Estimated Time:1m 0s
Question 60Question →

A 24-year-old woman comes to the outpatient psychiatric clinic due to a 4-week history of feeling severely depressed, lacking energy, and sleeping 12 to 14 hours a day. She reports a loss of interest in her usual hobbies and a 5-kg (11-lb) weight gain over this period. The patient has no significant past medical history. Upon further questioning, the patient's roommate states that 8 months ago, the patient had a 10-day episode where she was extremely energetic, required only 3 hours of sleep per night, and spoke so rapidly it was difficult to interrupt her. During that time, she spontaneously booked an expensive, non-refundable trip to Europe that she could not afford. She was not hospitalized and eventually returned to her baseline. Which of the following is the most appropriate pharmacotherapy for this patient's current condition?

Show answer & explanation

Answer: Quetiapine

Answer

The correct answer is quetiapine, which is indicated for the treatment of acute bipolar depression.
The correct answer is quetiapine. This patient's current presentation of depressed mood, hypersomnia, weight gain, and anhedonia is consistent with a major depressive episode. However, her history of a distinct 10-day period of elevated energy, decreased need for sleep, pressured speech, and impulsive behavior indicates a past manic or hypomanic episode. Therefore, her underlying diagnosis is bipolar disorder, and she is currently experiencing acute bipolar depression. The most appropriate initial pharmacotherapy for acute bipolar depression includes certain second-generation antipsychotics (e.g., quetiapine, lurasidone) or mood stabilizers (e.g., lithium, lamotrigine). Quetiapine is FDA-approved as a monotherapy for this condition and is an excellent first-line choice.

Step-by-Step Solution

1
Identify the patient's current clinical syndrome.
The patient is experiencing a major depressive episode, characterized by depressed mood, hypersomnia, weight gain, fatigue, and anhedonia for 4 weeks.
Establishing the current phase of the mood disorder is necessary to guide symptom-specific treatment.
2
Evaluate the patient's psychiatric history for prior mood episodes.
The patient had a previous 10-day episode of decreased need for sleep, rapid speech, increased energy, and impulsivity (booking an expensive trip).
A history of mania or hypomania fundamentally changes the diagnosis from major depressive disorder to bipolar disorder.
3
Determine the appropriate pharmacotherapy for acute bipolar depression.
Select an agent with proven efficacy for bipolar depression that does not risk inducing a manic switch, such as quetiapine.
Antidepressant monotherapy is contraindicated in bipolar disorder due to the risk of mood destabilization and manic switch.

Key Concept

Management of acute bipolar depression and avoidance of antidepressant monotherapy
PreviousPage 3 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 3 | Examkin